DTx Commercialization and Reimbursement

 View Only

About this Group

This group works through expanding and standardizing the commercial pathways for reimbursement of DTx products. The group is working to ensure the successful adoption of the Digital Mental Health Treatment (DMHT) codes, building formulary and medical policy standards, and dissecting successful launch strategies. Also monitors and informs ATA Action policy and legislative efforts.

SIG Leader

Latest Discussions

Announcements

Log in to see this information

Either the content you're seeking doesn't exist or it requires proper authentication before viewing.

Latest Library Entries